Tumor growth of individual mice within treatment groups showed a heterogeneous response to therapy (Fig. 2e) and was effectively inhibited in mice subjected to combined XRT and anti-CTLA-4 therapy compared to control (p = 0.0025) on day 22 (the last day of the control group), Fig. 2f. The gene discussed is CTLA4; the disease is neoplasm.